[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369899-105":59,"doc-detail-369899-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rev1-targeting-inhibitor-jh-re-06-induces-ferroptosis-via-ncoa4-mediated-ferritinophagy-in-colorectal-cancer-cells","REV1-targeting inhibitor JH-RE-06 induces ferroptosis via NCOA4-mediated ferritinophagy in colorectal cancer cells","","Oncogenes drive excessive DNA replication origin firing, causing replication stress (RS) and genomic instability in cancer cells, making RS a therapeutic target. Translesion synthesis (TLS) enables bypass of DNA damage and helps cancer cells survive and proliferate, yet the colorectal cancer use of the TLS polymerase REV1 inhibitor JH-RE-06 remains insufficiently characterized. Bioinformatics of TCGA clinical samples shows REV1 upregulation in colorectal tumors and association with worse prognosis. JH-RE-06 suppresses CRC tumorigenesis in vitro and in vivo and triggers ferroptosis-linked signaling via elevated oxidative stress. Transmission electron microscopy and biochemical assays support ferroptotic features, including autophagic vacuoles with engulfed mitochondria, increased Fe2+ and malondialdehyde, reduced glutathione, and reduced antioxidant proteins and ferritin. Mechanistic data further indicate NCOA4-mediated ferritinophagy and ferroptosis activation, with in vivo safety showing no notable major-organ pathology. These findings position REV1 and JH-RE-06 as potential diagnostic and therapeutic options for CRC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rev1-targeting-inhibitor-jh-re-06-induces-ferroptosis-via-ncoa4-mediated-ferritinophagy-in-colorectal-cancer-cells/369899/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rev1-targeting-inhibitor-jh-re-06-induces-ferroptosis-via-ncoa4-mediated-ferritinophagy-in-colorectal-cancer-cells/369899.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological problem does replication stress (RS) create in cancer cells?","Question",{"text":112,"@type":113},"Excessive replication origin firing induces replication stress and genomic instability, contributing to DNA damage in cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does JH-RE-06 affect colorectal cancer cells?",{"text":117,"@type":113},"JH-RE-06 suppresses colorectal cancer tumorigenesis in vitro and in vivo and induces cell death associated with ferroptosis-linked signaling.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism connects JH-RE-06 to ferroptosis?",{"text":121,"@type":113},"Drug rescue and proteomics indicate elevated oxidative stress and induction of ferroptosis-associated signaling, with NCOA4-mediated ferritinophagy and ferroptosis activation supported by gene knockdown experiments.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369899,1790466782,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","ONCOLOGY REPORTS 54: 159, 2025  \nREV1‑targeting inhibitor JH‑RE‑06 induces ferroptosis via NCOA4‑mediated ferritinophagy in colorectal cancer cells  \nJIANHUA CHENG 1,2* , XIAOXIA YANG3* , WEN ZHAO 1 , JIE XU 1 , YANJIE HAO 1 and FANG XU 1 1School of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui 750001, P.R. China; 2Ningxia Key Laboratory of  \n3  \nCraniocerebral Diseases, Ningxia Medical University, Yinchuan, Ningxia Hui 750001, P.R. China; Department of Anesthesia and Perioperative Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui 750004, P.R. China  \nReceived May 11, 2025; Accepted August 22, 2025  \nDOI: 10. 3892/or.2025.8992  \nAbstract. Oncogenes accelerate DNA replication, leading to the activation of excessive replication origins. This process triggers replication stress (RS) and genomic instability in cancer cells, positioning RS as a promising therapeutic target. Translesion synthesis (TLS) functions as a DNA damage repair bypass mechanism, compensating for RS and conferring a proliferation advantage to cancer cells. Despite its therapeutic potential, the application of the TLS polymerase REV1 (REV1 DNA directed polymerase (REV1) inhibitor JH‑RE‑06 in colorectal cancer (CRC) remains unexplored. Bioinformatics analysis of clinical samples from The Cancer Genome Atlas (TCGA) database demonstrated marked REV1 upregulation in colorectal tumors compared with normal tissues, which was associated with a poorer prognosis. JH‑RE‑06 effectively suppressed CRC tumorigenesis both in vitro and in vivo. Mechanistically, drug rescue experiments and proteomics revealed that cell death triggered by JH‑RE‑06 was associated with elevated oxidative stress and induction offerroptosis‑asso‑ ciated signaling. Transmission electron microscopy revealed characteristic morphological changes associated with ferrop‑ tosis, including a significant reduction in mitochondrial abundance and the presence of autophagic vacuoles containing engulfed mitochondria. Biochemical assays confirmed that JH‑RE‑06 significantly increased intracellular Fe²+ and malondialdehyde (MDA) levels while reducing glutathione levels, indicative of ferroptosis. Western blot analysis revealed decreased levels of antioxidant proteins, including superoxide dismutase 2 (SOD2) and glutamate‑cysteine ligase catalytic subunit (GCLC), as well as ferritin. Furthermore, western blot  \nCorrespondence to: Professor Fang Xu, School of Basic Medicine, Ningxia Medical University, Housheng Building, 1160 Shengli South Street, Yinchuan, Ningxia Hui 750001, P.R. China  \nE‑mail: [xufang_1@nxmu.edu.cn](xufang_1@nxmu.edu.cn)  \n*Contributed equally  \nKey words: REV1, JH‑RE‑06, colorectal cancer, NCOA4, ferroptosis  \nand FerroOrange assays, combined with Autophagy‑related Gene 7 (ATG7) and Nuclear Receptor Coactivator 4 (NCOA4) knockdown experiments, demonstrated that JH‑RE‑06 acti‑ vated ferroptosis in CRC via NCOA4‑mediated ferritinophagy. Safety evaluation via hematoxylin and eosin staining of major organs in mice showed no notable pathological damage induced by JH‑RE‑06 . Taken together, these findings establish REV1 as a potential diagnostic biomarker and therapeutic target in CRC. REV1 inhibitor JH‑RE‑06 promoted NCOA4‑mediated ferritinophagy and induced programmed cell death, thereby highlighting its potential as a safe and effective therapeutic strategy for CRC.  \nIntroduction  \nGlobally, colorectal cancer (CRC) accounted for >1.9 million newly diagnosed cases of cancer in 2020, leading to almost 935,000 fatalities. This accounted for one‑tenth of all cancer cases and deaths (1) . While chemotherapy is the standard treatment for metastatic CRC, the median overall survival is 20 months (2), and the 5‑year survival rate is 12%(3) . These statistics reveal the need to unravel the molecular basis of treatment resistance and develop targeted therapies that induce novel forms of programmed cell death (PCD) . Although onco‑ gene activation, a hallmar","cbCaihxv41UtsulP","https://ap.wps.com/l/cbCaihxv41UtsulP","pdf",16156295,13,"English","# Abstract\n# Introduction\n## Replication stress and cancer survival mechanisms\n## TLS and the role of REV1\n## Rationale for targeting REV1 in colorectal cancer\n# (Further sections not provided)","[{\"question\":\"What biological problem does replication stress (RS) create in cancer cells?\",\"answer\":\"Excessive replication origin firing induces replication stress and genomic instability, contributing to DNA damage in cancer cells.\"},{\"question\":\"How does JH-RE-06 affect colorectal cancer cells?\",\"answer\":\"JH-RE-06 suppresses colorectal cancer tumorigenesis in vitro and in vivo and induces cell death associated with ferroptosis-linked signaling.\"},{\"question\":\"What mechanism connects JH-RE-06 to ferroptosis?\",\"answer\":\"Drug rescue and proteomics indicate elevated oxidative stress and induction of ferroptosis-associated signaling, with NCOA4-mediated ferritinophagy and ferroptosis activation supported by gene knockdown experiments.\"}]","REV1-targeting inhibitor JH-RE-06 induces ferroptosis via NCOA4-mediated ferritinophagy in colorectal cancer cells | PDF",1790185141,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/823484d8d3b340949e979a8abffb1df1.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6871ef8ce511e373dc18f96873be6e13.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4beea37d8a7053770e1e20f56f13069.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5ddc5881d749d5d8b1e771a39c2291b.webp",980,1353]